Overview

Insulin Tolerance Test Study in Patients With Type 1 Diabetes

Status:
Terminated
Trial end date:
2020-02-16
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to determine the safety, tolerability and pharmacodynamics of pitolisant in patients with Type 1 Diabetes
Phase:
Phase 1
Details
Lead Sponsor:
Clayton A. Dehn
High Point Clinical Trials Center
Collaborator:
Ferox Therapeutics